Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Zost

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active siteTy A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
The Journal of Clinical Investigation|June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
The Journal of Clinical Investigation|August 4, 2025
Corrigendum to Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza seasonSusanne L Linderman, Benjamin S Chambers, Seth J Zost, et al.
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|December 1, 2025
A protective and heterosubtypic antibody lineage targeting the influenza A virus neuraminidase active siteTy A Sornberger, Rachael M Wolters, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions and monocytes for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
The Journal of Clinical Investigation|June 22, 2021
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2020
Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
Cell Host & Microbe|December 1, 2020
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionAllison J Greaney, Tyler N Starr, Pavlo Gilchuk, et al.
The Journal of Clinical Investigation|August 4, 2025
Corrigendum to Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interfaceSeth J Zost, Jinhui Dong, Iuliia M Gilchuk, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 22, 2014
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza seasonSusanne L Linderman, Benjamin S Chambers, Seth J Zost, et al.
Cell|March 10, 2021
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protectionEmma S Winkler, Pavlo Gilchuk, Jinsheng Yu, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individualsElaine C Chen, Pavlo Gilchuk, Seth J Zost, et al.
Nature|May 15, 2024
Imprinting of serum neutralizing antibodies by Wuhan-1 mRNA vaccinesChieh-Yu Liang, Saravanan Raju, Zhuoming Liu, et al.
Pageof 5